Literature DB >> 30345935

Comparison of Rat and Human Pulmonary Metabolism Using Precision-cut Lung Slices (PCLS).

Yildiz Yilmaz1, Gareth Williams1, Markus Walles1, Nenad Manevski1, Stephan Krähenbühl2, Gian Camenisch1.   

Abstract

BACKGROUND: Although the liver is the primary organ of drug metabolism, the lungs also contain drug-metabolizing enzymes and may, therefore, contribute to the elimination of drugs. In this investigation, the Precision-cut Lung Slice (PCLS) technique was standardized with the aims of characterizing and comparing rat and human pulmonary drug metabolizing activity.
METHOD: Due to the limited availability of human lung tissue, standardization of the PCLS method was performed with rat lung tissue. Pulmonary enzymatic activity was found to vary significantly with rat age and rat strain. The Dynamic Organ Culture (DOC) system was superior to well-plates for tissue incubations, while oxygen supply appeared to have a limited impact within the 4h incubation period used here.
RESULTS: The metabolism of a range of phase I and phase II probe substrates was assessed in rat and human lung preparations. Cytochrome P450 (CYP) activity was relatively low in both species, whereas phase II activity appeared to be more significant.
CONCLUSION: PCLS is a promising tool for the investigation of pulmonary drug metabolism. The data indicates that pulmonary CYP activity is relatively low and that there are significant differences in enzyme activity between rat and human lung. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  AFQ056; Precision-cut lung slices (PCLS); dynamic organ culture system; human lung metabolism; pulmonary disposition of phase I and phase II drugs; rat and human pulmonary metabolismzzm321990activity; rat lung metabolism.

Mesh:

Substances:

Year:  2019        PMID: 30345935     DOI: 10.2174/1872312812666181022114622

Source DB:  PubMed          Journal:  Drug Metab Lett        ISSN: 1872-3128


  9 in total

1.  In vitro airway models from mice, rhesus macaques, and humans maintain species differences in xenobiotic metabolism and cellular responses to naphthalene.

Authors:  Jacklyn Kelty; Nataliia Kovalchuk; Eric Uwimana; Lei Yin; Xinxin Ding; Laura Van Winkle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-07-19       Impact factor: 6.011

2.  Tissue Distribution of Oleocanthal and Its Metabolites after Oral Ingestion in Rats.

Authors:  Anallely López-Yerena; Anna Vallverdú-Queralt; Olga Jáuregui; Xavier Garcia-Sala; Rosa M Lamuela-Raventós; Elvira Escribano-Ferrer
Journal:  Antioxidants (Basel)       Date:  2021-04-27

Review 3.  Precision-cut lung slices: A powerful ex vivo model to investigate respiratory infectious diseases.

Authors:  Flávia Viana; Cecilia M O'Kane; Gunnar N Schroeder
Journal:  Mol Microbiol       Date:  2021-10-31       Impact factor: 3.979

4.  Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model.

Authors:  Katarina Rubin; Pär Ewing; Erica Bäckström; Anna Abrahamsson; Britta Bonn; Satoshi Kamata; Ken Grime
Journal:  Pharmaceutics       Date:  2020-02-01       Impact factor: 6.321

5.  The Challenge of Long-Term Cultivation of Human Precision-Cut Lung Slices.

Authors:  Eike B Preuß; Stephanie Schubert; Christopher Werlein; Helge Stark; Peter Braubach; Anne Höfer; Edith K J Plucinski; Harshit R Shah; Robert Geffers; Katherina Sewald; Armin Braun; Danny D Jonigk; Mark P Kühnel
Journal:  Am J Pathol       Date:  2021-11-10       Impact factor: 4.307

Review 6.  Odorant Metabolism in Humans.

Authors:  Nicole Kornbausch; Marcel W Debong; Andrea Buettner; Jean-Marie Heydel; Helene M Loos
Journal:  Angew Chem Int Ed Engl       Date:  2022-07-28       Impact factor: 16.823

Review 7.  Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening.

Authors:  Aylin Cidem; Peta Bradbury; Daniela Traini; Hui Xin Ong
Journal:  Front Bioeng Biotechnol       Date:  2020-10-23

8.  Inferring pulmonary exposure based on clinical PK data: accuracy and precision of model-based deconvolution methods.

Authors:  Anneke Himstedt; Jens Markus Borghardt; Sebastian Georg Wicha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-09-28       Impact factor: 2.745

Review 9.  New Approach Methods to Evaluate Health Risks of Air Pollutants: Critical Design Considerations for In Vitro Exposure Testing.

Authors:  Jose Zavala; Anastasia N Freedman; John T Szilagyi; Ilona Jaspers; John F Wambaugh; Mark Higuchi; Julia E Rager
Journal:  Int J Environ Res Public Health       Date:  2020-03-23       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.